Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.
Efstathios KastritisIoannis Ntanasis-StathopoulosFoteini TheodorakakouMagdalini MigkouMaria RoussouPanagiotis MalandrakisNikolaos KanelliasEvangelos Eleutherakis-PapaiakovouDespina FotiouVassiliki SpiliopoulouMaria GavriatopoulouSachin PatelIstvan MajerChristos BoukisAndriani FetaniMeletios A DimopoulosEvangelos TerposPublished in: Clinical lymphoma, myeloma & leukemia (2024)
In this real-world Len-exposed cohort, Len-refractory patients receiving 1L Len experienced poorer survival outcomes than non-Len-refractory patients, highlighting the unmet need in this patient population which has driven the development of novel therapies.
Keyphrases
- multiple myeloma
- newly diagnosed
- end stage renal disease
- ejection fraction
- chronic kidney disease
- acute myeloid leukemia
- peritoneal dialysis
- acute lymphoblastic leukemia
- emergency department
- case report
- diffuse large b cell lymphoma
- stem cells
- stem cell transplantation
- low dose
- mesenchymal stem cells
- skeletal muscle
- insulin resistance
- chronic lymphocytic leukemia